220 related articles for article (PubMed ID: 20353406)
1. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
2. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
Johnson DB; Savani BN
Exp Hematol; 2012 Jul; 40(7):513-7. PubMed ID: 22542577
[TBL] [Abstract][Full Text] [Related]
3. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation.
Tsakiris DA
Haematologica; 2006 Jun; 91(6):726B. PubMed ID: 16769572
[No Abstract] [Full Text] [Related]
5. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
Tay J; Tinmouth A; Fergusson D; Huebsch L; Allan DS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):206-17. PubMed ID: 17241926
[TBL] [Abstract][Full Text] [Related]
6. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
[No Abstract] [Full Text] [Related]
7. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
8. In brief: Defibrotide (Defitelio) for hepatic veno-occlusive disease.
Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603963
[No Abstract] [Full Text] [Related]
9. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
10. SOS for veno-occlusive disease: defibrotide prophylaxis.
Platzbecker U; Bornhäuser M
Lancet; 2012 Apr; 379(9823):1277-8. PubMed ID: 22364686
[No Abstract] [Full Text] [Related]
11. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
Shah MS; Jeevangi NK; Joshi A; Khattry N
J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
[TBL] [Abstract][Full Text] [Related]
12. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
Ho VT; Revta C; Richardson PG
Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
[TBL] [Abstract][Full Text] [Related]
13. Venous occlusive disease in children.
Gharib MI; Bulley SR; Doyle JJ; Wynn RF
Thromb Res; 2006; 118(1):27-38. PubMed ID: 16154622
[No Abstract] [Full Text] [Related]
14. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
15. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review.
Zhang L; Wang Y; Huang H
Clin Transplant; 2012; 26(4):511-9. PubMed ID: 22428954
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction.
Bunte MC; Patnaik MM; Pritzker MR; Burns LJ
Bone Marrow Transplant; 2008 Apr; 41(8):677-86. PubMed ID: 18223697
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
[TBL] [Abstract][Full Text] [Related]
18. Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide.
Pol RR; Russell N; Das-Gupta E; Watson L; Rachael L; Byrne J
Bone Marrow Transplant; 2016 Sep; 51(9):1262-4. PubMed ID: 27111044
[No Abstract] [Full Text] [Related]
19. Can defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?
Shah NC; Shenoy S
Lancet Haematol; 2023 May; 10(5):e309-e311. PubMed ID: 37001535
[No Abstract] [Full Text] [Related]
20. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
